Allergic Contact Dermatitis

• FDA approval · 2025-02-26
  FDA Approved: FLUOCINONIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)

  FDA approved fluocinonide from Quagen Pharmaceuticals LLC under an Original Application (ANDA 216389). This is a generic topical corticoster…

• FDA approval · 2024-12-09
  FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approval of Hikma's generic Triamcinolone Acetonide (ANDA 215254) as an original-application topical corticosteroid product for dermatol…

• FDA approval · 2023-12-28
  FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)

  The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…

• FDA approval · 2023-11-29
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approves Glenmark's supplemental application for clobetasol propionate, a potent topical corticosteroid, enabling an approved supplement…

• FDA approval · 2021-02-05
  FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approves a generic Triamcinolone Acetonide topical product under an Original Application (ANDA) for Padagis Israel Pharmaceuticals Ltd.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2020-07-14
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Viona Pharmaceuticals Inc)

  FDA approved the original application for Betamethasone Dipropionate by Viona Pharmaceuticals Inc, granting it as a generic topical corticos…

• FDA approval · 2019-12-18
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approved an original application for Betamethasone dipropionate by Lupin Pharmaceuticals, Inc., granting a generic topical corticosteroi…

• FDA approval · 2018-12-14
  FDA Approved: HYDROCORTISONE VALERATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's hydrocortisone valerate as a generic topical corticosteroid under an original ANDA (ANDA211750).

• FDA approval · 2018-03-26
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a generic clobetasol propionate topical product from Glenmark Pharmaceuticals (ANDA 209004) for treatment of inflammatory and p…

• FDA approval · 2013-08-09
  FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a generic topical fluocinonide acetonide product under an original application from Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2012-01-03
  FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc., resulting in changes to the product lab…

• FDA approval · 2011-07-26
  FDA Approved: ALCLOMETASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for aclometasone dipropionate from Sun Pharmaceutical Industries, Inc. The approval confirms the cha…

• FDA approval · 2007-11-28
  FDA Approved: HYDROCORTISONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a supplemental application for Hydrocortisone by Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's appr…